On June 15, authoritative experts from Beijing Friendship Hospital, Beijing Fuxing Hospital, and Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology gathered in Wuhan to personally verify and confirm on-site: the 7-mm blood vessel of the Ureka radiofrequency ultrasonic scalpel in the animal test was successfully and reliably coagulated, and the data was successful in many aspects!
The animal experiments of the Ureka radiofrequency ultrasonic scalpel not only witnessed its excellent performance in large blood vessel coagulation, but also marked an important technological breakthrough for domestic medical devices in the field of surgery, providing strong data support for future clinical applications.
Ureka radio frequency ultrasonic scalpel uses radio frequency and ultrasonic combined energy technology, which can simultaneously output ultrasonic waves and high-frequency electricity to cut and stop bleeding in soft tissues, and coagulate large blood vessels with a diameter of ≤7mm. It has obtained the national Class III medical device registration certificate.
The product combines bipolar coagulation function and quick-change knife tube technology. Clinically, it has faster cutting speed, stronger coagulation function and smaller heat loss, which greatly improves the convenience and safety of surgery.
Professor Chen Zhaohui, an expert in urology at Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, who participated in animal experiments, spoke highly of the Ureka radiofrequency ultrasound scalpel. He said that in this animal experiment, the Ureka radiofrequency ultrasonic scalpel can completely independently seal and disconnect the pig spleen blood vessels, and completely close and disconnect the pig renal arteries and veins.
Professor Chen Zhaohui further pointed out that if the Ureka radiofrequency ultrasonic scalpel can perfectly treat these two groups of blood vessels, then the problems of other peripheral blood vessels in the human body will also be solved. This undoubtedly brings new hope to the surgical community, and Wuhan Half the Sky has created a miracle!
The success of the animal experiment of Ureka’s radiofrequency ultrasonic scalpel is undoubtedly the best feedback for the hard work of the Half the Sky R&D team and the valuable support of many experts and professors. We would like to express our sincere gratitude!
Wuhan Half the Sky will combine the valuable data obtained from this animal experiment to continue to optimize and improve the performance of the Ureka radiofrequency ultrasound scalpel. We look forward to the Ureka radiofrequency ultrasound scalpel product being widely used in clinical practice as soon as possible, covering more hospitals with better cost performance, and bringing health benefits to more patients!
